Child-Na score: A predictive model for survival in cirrhotic patients with symptomatic portal hypertension treated with TIPS

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Chen, Hui ^a   Bai, Ming ^a   Qi, Xingshun ^a   Liu, Lei ^a   He, Chuangye ^a   Yin, Zhanxin ^a   Fan, Daiming ^a   Han, Guohong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM;

ADULT; AGED; ARTICLE; CHILD PUGH SCORE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EVIDENCE BASED PRACTICE; FEMALE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; PROPORTIONAL HAZARDS MODEL; REFERENCE VALUE; RISK ASSESSMENT; SODIUM BLOOD LEVEL; SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT INDICATION; TREATMENT RESPONSE; VERY ELDERLY; YOUNG ADULT; BLOOD; CAUSE OF DEATH; COMPLICATION; HYPERTENSION, PORTAL; MIDDLE AGED; MORTALITY; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; FEMALE; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROGNOSIS; REFERENCE VALUES; ROC CURVE; SODIUM; YOUNG ADULT;

EID: 84893205556     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079637     Document Type: Article

References (33)

1. Montgomery A, Ferral H, Vasan R, Postoak DW (2005) MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures. Cardiovasc Intervent Radiol 28: 307-312. (Pubitemid 40880749)
2. Bureau C, Garcia-Pagan JC, Otal P, Pomier-Layrargues G, Chabbert V, et al. (2004) Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 126: 469-475. (Pubitemid 38182304)
3. Boyer TD, Haskal ZJ (2010) The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension: update 2009. Hepatology 51: 306.
4. Angermayr B, Cejna M, Koenig F, Karnel F, Hackl F, et al. (2003) Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents. Hepatology 38: 1043-1050. (Pubitemid 37221688)
5. Charon JP, Alaeddin FH, Pimpalwar SA, Fay DM, Olliff SP, et al. (2004) Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 15: 1219-1230. (Pubitemid 39487851)
6. Maleux G, Nevens F, Wilmer A, Heye S, Verslype C, et al. (2004) Early and long-term clinical and radiological follow-up results of expanded- polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures. Eur Radiol 14: 1842-1850. (Pubitemid 39386633)
7. Hausegger KA, Karnel F, Georgieva B, Tauss J, Portugaller H, et al. (2004) Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft. J Vasc Interv Radiol 15: 239-248. (Pubitemid 38316445)
8. Angeloni S, Merli M, Salvatori FM, De Santis A, Fanelli F, et al. (2004) Polytetrafluoroethylene-covered stent grafts for TIPS procedure: 1-year patency and clinical results. Am J Gastroenterol 99: 280-285. (Pubitemid 38279870)
9. Barrio J, Ripoll C, Banares R, Echenagusia A, Catalina MV, et al. (2005) Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents. Eur J Radiol 55: 120-124. (Pubitemid 40798497)
10. Vignali C, Bargellini I, Grosso M, Passalacqua G, Maglione F, et al. (2005) TIPS with expanded polytetrafluoroethylene-covered stent: results of an Italian multicenter study. AJR Am J Roentgenol 185: 472-480.
11. Bureau C, Pagan JC, Layrargues GP, Metivier S, Bellot P, et al. (2007) Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int 27: 742-747. (Pubitemid 47062040)
12. Giannini E, Botta F, Fumagalli A, Malfatti F, Testa E, et al. (2004) Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients? Liver Int 24: 465-470. (Pubitemid 40484561)
13. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, et al. (2006) Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 130: 1652-1660. (Pubitemid 43668830)
14. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, et al. (2008) Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 359: 1018-1026.
15. Rubin RA, Haskal ZJ, O'Brien CB, Cope C, Brass CA (1995) Transjugular intrahepatic portosystemic shunting: decreased survival for patients with high APACHE II scores. Am J Gastroenterol 90: 556-563.
16. Brensing KA, Raab P, Textor J, Gorich J, Schiedermaier P, et al. (2002) Prospective evaluation of a clinical score for 60-day mortality after transjugular intrahepatic portosystemic stent-shunt: Bonn TIPSS early mortality analysis. Eur J Gastroenterol Hepatol 14: 723-731. (Pubitemid 34753955)
17. Schepke M, Roth F, Fimmers R, Brensing KA, Sudhop T, et al. (2003) Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol 98: 1167-1174. (Pubitemid 36733783)
18. Chalasani N, Clark WS, Martin LG, Kamean J, Khan MA, et al. (2000) Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 118: 138-144. (Pubitemid 30020381)
19. Bureau C, Metivier S, D'Amico M, Peron JM, Otal P, et al. (2011) Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS. J Hepatol 54: 901-907.
20. Han G, Qi X, He C, Yin Z, Wang J, et al. (2011) Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol 54: 78-88.
21. Qi X, Han G, Yin Z, He C, Wang J, et al. (2012) Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients. Dig Dis Sci 57: 1072-1082.
22. Schuppan D, Afdhal NH (2008) Liver cirrhosis. Lancet 371: 838-851. (Pubitemid 351323895)
23. Chen H, Qi X, He C, Yin Z, Fan D, et al. (2013) Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis. Thromb Res 131: 173-177.
24. Thompson C, Hoorn EJ (2012) Hyponatraemia: an overview of frequency, clinical presentation and complications. Best Pract Res Clin Endocrinol Metab 26 Suppl 1: S1-6.
25. Moore KP, Wong F, Gines P, Bernardi M, Ochs A, et al. (2003) The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 38: 258-266. (Pubitemid 36775818)
26. Gaba RC, Couture PM, Bui JT, Knuttinen MG, Walzer NM, et al. (2013) Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 24: 411-420, 420 e411-414; quiz 421.
27. Reuben A (2002) Child comes of age. Hepatology 35: 244-245.
28. Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, et al. (2003) Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 52: 879-885. (Pubitemid 36613497)
29. Kamath PS, Kim WR (2007) The model for end-stage liver disease (MELD). Hepatology 45: 797-805. (Pubitemid 46450631)
30. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, et al. (2005) Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 11: 336-343. (Pubitemid 40458408)
31. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, et al. (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31: 864-871. (Pubitemid 30169932)
32. Gerbes AL, Gulberg V, Gines P, Decaux G, Gross P, et al. (2003) Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial. Gastroenterology 124: 933-939. (Pubitemid 36389796)
33. Wong F, Blei AT, Blendis LM, Thuluvath PJ (2003) A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial. Hepatology 37: 182-191. (Pubitemid 36042159)